Clinical trial
Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II…
NCT00003500 · Burzynski Research Institute, Other · Terminated
Key facts
| NCT number | NCT00003500 |
|---|---|
| Title | Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma |
| Official title | Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, Intermediate Grade |
| Lead sponsor | Burzynski Research Institute, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-hodgkins Lymphoma |
| Intervention type | Drug |
| Interventions | Antineoplaston therapy (Atengenal + Astugenal) |
| Enrollment | 12 |
| Start date | Mar 11, 1996 |
| Primary completion | Jun 16, 2000 |
| Completion | Jun 16, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: